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Abstract
Postherpetic neuralgia (PHN), the most common complication of herpes zoster (HZ), plays a major role in decreased life
quality of HZ patients. However, the neural mechanisms underlying PHN remain unclear. Here, using a PHN rat model at 2
weeks after varicella zoster virus infection, we found that spinal astrocytes were dramatically activated. The mechanical
allodynia and spinal central sensitization were significantly attenuated by intrathecally injected L-a-aminoadipate (astrocytic
specific inhibitor) whereas minocycline (microglial specific inhibitor) had no effect, which indicated that spinal astrocyte but
not microglia contributed to the chronic pain in PHN rat. Further study was taken to investigate the molecular mechanism
of astrocyte-incudced allodynia in PHN rat at post-infection 2 weeks. Results showed that nitric oxide (NO) produced by
inducible nitric oxide synthase mediated the development of spinal astrocytic activation, and activated astrocytes
dramatically increased interleukin-1b expression which induced N-methyl-D-aspartic acid receptor (NMDAR) phosphory-
lation in spinal dorsal horn neurons to strengthen pain transmission. Taken together, these results suggest that spinal
activated astrocytes may be one of the most important factors in the pathophysiology of PHN and ‘‘NO-Astrocyte-Cytokine-
NMDAR-Neuron’’ pathway may be the detailed neural mechanisms underlying PHN. Thus, inhibiting spinal astrocytic
activation may represent a novel therapeutic strategy for clinical management of PHN.
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Introduction
The most common complication of herpes zoster (HZ) is
postherpetic neuralgia (PHN) which has been defined as severe
pain occurring 1 month after rash onset and persisting for more
than 3 months [1]. PHN is often prolonged, responds poorly to
current analgesics such as anticonvulsants, tricyclic antidepressants,
opioids and non-steroidal anti-inflammatory drugs (NSAIDS) [2].
PHN can result in impaired sleep, emotional distress and depression
which patients may suffer for years [3]. Continued inflammation
was observed in biopsy studies of somePHN patients, whereas PHN
is resistant to NSAIDS, suggesting that inflammatory response per
se is not sufficient to induce PHN [4,5]. Recently, it has been
pointed out that PHN shares some characteristics of neuropathic
pain [6]. Forexample,up-regulationof some neuropeptide, calcium
channel and sodium channel has been observed in dorsal root
ganglia of PHN rat model. Besides, systemic treatment with
gabapentin or the sodium channel blockers could to some extent
reverse PHN [7]. However, there is still no ideal explanation on the
neural mechanisms underlying PHN.
According to classic pain research, the pain pathway has been
assumed to be composed &&entirely of neuronal synaptic
transmission. It has been widely accepted that activation of N-
methyl-D-aspartate receptor (NMDAR) in spinal postsynaptic
neurons plays an important role in neuropathic pain, and
NMDAR antagonists are potential analgesics [8,9]. NMDAR
activation is mainly manifested by NR1 subunit phosphorylation,
which is proposed to be involved in spinal central sensitization
[10,11]. However, recent studies have shown that spinal cord glia
and proinflammatory cytokines, such as interleukin (IL)-1b, are
also identified to be strongly involved in the creation and
maintenance of diverse exaggerated neuropathic pain states
[12,13]. After inflammation or nerve injury, spinal glial cells can
be activated by excessively produced nitric oxide (NO), and then
synthesize and release IL-1b that modulate neuronal activity
[14,15]. Several recent studies showed that IL-1b may bind to its
endogenous receptor to induce the phosphorylation of NR1
subunit of NMDAR to strengthen painful signal transmission
[16,17]. However, there is still no related report on the
involvement of spinal glial cells in PHN.
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been facilitated by the introduction of an in vivo rat model of
varicella zoster virus (VZV) persistent infection [18,19]. Recent
studies indicated that this rat model could ideally mimic the
chronic pain states that occur in PHN patients [20,21]. In this
study, we investigated the role of spinal glia in the pathophysiology
of PHN by using this PHN model. L-a-aminoadipate (LAA) and
minocycline were used to inactivate astrocyte and microglia,
respectively, to identify the roles of spinal glial cells in the
development of PHN. LAA was used to inhibit astrocytes based on
the fact that its role of a specific astrocytic toxin [22]. In addition,
intrathecal treatment with inhibitors of nitric oxide synthase
(NOS) or scavenger of NO was performed to test whether NO
mediate the development of glial activation. The mediating role of
inflammatory cytokine on NMDAR activation was also investi-
gated.
Materials and Methods
Animals
Adult male Wistar rats, weighing 200–250 g, were used. Rats
were housed under standard conditions. All procedures of our
experiments were approved by the Committee of Animal Use for
Research and Education of the Fourth Military Medical
University (Xi’an, PR China), and all efforts were made to
minimize the number of animals used and their suffering [23].
(Permit Number: fmmu-10-6688).
Varicella zoster virus (VZV) infection
We utilized a previously reported PHN model of latent VZV
infection [18,20,21]. VZV (VR-568 mycoplasma free strain
obtained from ATCC, VA, USA) was propagated on CV-1 cells
(African green monkey kidney fibroblast cells) and harvested in
0.0l M phosphate-buffered saline (PBS, pH 7.4) when the cells
exhibited an 80% cytopathic effect. Rats were anaesthetised with
halothane and the plantar surface of the right hindpaw was
injected with 50 ml of inoculum containing 6610
6 VZV-infected
cells (VZV group). The contralateral hindpaw was without
infection. Control rats were injected with uninfected CV-1 cells
(Mock infected group) or PBS (Naı ¨ve group) and housed separately
from VZV group. Pain behavioural tests were performed prior to
infection to obtain a baseline and then at specific time points post-
infection.
Antibodies
Primary antibodies: mouse anti-GFAP IgG (astrocytic marker;
Chemicon, Temecula, CA, USA), mouse anti-NeuN IgG
(neuronal marker; Chemicon), mouse anti-OX42 IgG (microglial
marker; Chemicon), rabbit anti-IL-1b IgG (Endogen, Rockford,
IL, USA), rabbit anti-P-ser896 NR1 IgG (Millipore, Bedford, MA,
USA), rabbit anti-iNOS IgG (Calbiochem, San Diego, CA, USA),
rabbit anti-nNOS IgG (Calbiochem) and rat anti-IL-1RI IgG
(Santa Cruz Biotechnology; Santa Cruz, CA, USA). Secondary
antibodies: FITC or Cy3-labeled donkey anti-mouse IgG
(Chemicon), FITC or Cy3-labeled donkey anti-rabbit IgG
(Chemicon), FITC or Cy3-labeled donkey anti-rat IgG (Chemi-
con).
Drugs
Chemicals and their sources were as follows: L-a-aminoadipate
(LAA, astrocytic specific inhibitor; Sigma, St. Louis, MO, USA),
minocycline (microglial specific inhibitor; Sigma), 2-(4-carboxy-
phenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (PTIO,
scavenger of NO; Sigma), L-N6-(I-iminoethyl)-lysine hydrochlo-
ride (L-NIL, inhibitor of iNOS; Sigma), 7-Nitroindazole (7-NINA,
inhibitor of nNOS; Sigma), pentoxifylline (cytokine inhibitor;
Polfilin, Polfarma, Poland), interleukin-1 receptor antagonist (IL-
1ra; Amgen, Thousand Oaks, CA, USA), 5-aminophosphonova-
leric acid (AP5, NMDA receptor antagonist; Sigma) and (5R,10S)-
(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclo-hepten-5,10-im-
ine hydrogen maleate (MK-801, non-competitive NMDA receptor
antagonist; Sigma), valaciclovir (Glaxo Wellcome, USA).
Experimental design
In the first series of experiments, rats were divided into Naive
group, Mock infected group and VZV group. At post-infection
different time points (per week after VZV infection), pain
behavior, immunostaining, Western blot and real-time RT-PCR
studies were performed in each group. Also, some VZV infected
rats received antiviral treatment (Valaciclovir, 50 mg/kg/day
from post-infection day 1 to day 10, i.p) and pain behavior was
detected per week after infection. (n=10/group; Fig. 1A).
In the second series of experiments, saline, LAA, minocycline,
PTIO, L-NIL, 7-NINA, pentoxifylline, IL-1ra, AP5 or MK-801
was injected intrathecally in VZV-infected rats at post-infection 2
weeks. After injection, pain behavior was immediately measured
(n=10/group).
In the third series of experiments, rats at post-infection 2 weeks
were used. LAA or minocycline was injected intrathecally, and one
hour later a total of 30 wide dynamic range (WDR) neurons were
recorded in each group (naive group, mock infected group, VZV
group, VZV+LAA group and VZV+minocycline group; n=30/
group).
In the fourth series of experiments, rats at post-infection 2 weeks
were used. Firstly, the L5 dorsal root ganglia and spinal cord
segments were harvested for Western blot analysis of iNOS or
nNOS in Naive group, Mock infected group and VZV group
(n=10/group). Secondly, double-labeling immunofluorescence of
iNOS with NeuN , GFAP or OX42 was performed in dorsal root
ganglia or spinal cord sections (n=10/group). Thirdly, PTIO, L-
NIL or 7-NINA was injected intrathecally, and one hour later the
spinal cords of VZV-infected rats were harvested for Western blot
analysis of GFAP (n=10/group).
In the fifth series of experiments, LAA was injected intrathecally
in VZV-infected rats at post-infection 2 weeks, and one hour later
spinal cords were harvested for Western blot analysis of IL-1b
(n=10). Double-labeling immunofluorescence of IL-1b with
GFAP or OX42 was performed in the L5 spinal cord sections.
In the sixth series of experiments, LAA, pentoxifylline or IL-1ra
was injected intrathecally in VZV-infected rats at post-infection 2
weeks, and one hour later the spinal cords were harvested for
Western blot analysis of P-NR1 (n=10/group). Double-labeling
immunofluorescence of IL-1RI and P-NR1 was performed in the
L5 spinal cord sections.
Intrathecal catheter insertion and drug administration
A polyethylene-10 catheter (Becton-Dickinson, Sparks, MD,
USA) was intrathecally inserted according to a previous method
[24]. The rats were allowed to recover for 3 days. Only the rats
judged as neurologically normal were used for the subsequent drug
administration. The dosage of each drug used in the present study
was according to the previous reports [25,26,27,28,29,30].
Treatment group received intrathecal injection of LAA (100 nmol)
[25], minocycline (100 mg) [26], L-NIL (1.1 mmol) [27], PTIO
(30 mg) [28], 7-NINA (20 mg) [27], AP5 (40 pmol) [27], MK-801
(100 pmol) [27], pentoxifylline (150 nmol) [29] or IL-1ra (100 mg)
[30], while the same volume of normal saline was injected in
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injected intrathecally by the way of a single acute administration.
Pain behavioral test
The rats were adapted to the testing situation for at least
15 min. The observers of the behaviors were blind to the
treatment of the rats. As previously described [31], a set of von
Frey monofilaments (Stoelting, Chicago, IL, USA) was used to test
the mechanical withdrawal threshold of the hindpaws. The
monofilaments were applied with increasing force until the rats
withdrew the paw. The threshold was taken as the lowest force
that evoked a brisk withdrawal response. To observe how different
drug treatments affected the allodynia, behavioral tests were
performed 12 h before the drugs administration to provide
baseline scores. After intrathecal drug injection, mechanical
withdrawal threshold was measured for every 10 min.
Immunofluorescence histochemical staining
Tissue preparation. Rats were anesthetized and perfused
transcardially with paraformaldehyde. The L5 dorsal root ganglia
(DRG) and the L5 spinal cord were removed and transferred into
30% sucrose in 0.1 M phosphate buffer (PB, pH 7.4) for
cryoprotection. Spinal cord was cut into 30 mm thick sections
and collected in 0.01 M phosphate-buffered saline (PBS, pH 7.4).
The DRG was cut into longitudinal sections measuring 10 mm
thick and mounted onto gelatin-coated glass slides. 10
representative tissue sections from each rat were selected (10
rats/group). After being blocked with 10% normal goat serum
(NGS), sections were incubated with corresponding antibodies.
Single immunofluorescence. After washed in PBS
containing 0.3% Triton X-100 (PBS-X, pH 7.4), the spinal cord
sections were incubated sequentially with: (1) mouse anti-GFAP
IgG (1:500) or mouse anti-OX42 IgG (1:200) in 0.0l M PBS
containing 5% (v/v) normal donkey serum (NDS), 0.3% (v/v)
Triton X-100, 0.05% (w/v) NaN3 and 0.25% (w/v) carrageenan
(PBS-NDS, pH 7.4) for 48 h at 4uC; (2) FITC-labeled donkey
anti-mouse IgG (1:200) in PBS-NDS for 12 h at 4uC.
Double immunofluorescence. Rabbit anti-IL-1b IgG
(1:300), rabbit anti-P-ser896 NR1 IgG (1:500), rat anti-IL-1RI
IgG (1:600) and rabbit anti-iNOS IgG (1:400) were respectively
double labelled with mouse anti-GFAP IgG (1:500), mouse anti-
NeuN IgG (1:1000) or mouse anti-OX42 IgG (1:200) in the spinal
cord sections; rabbit anti-P-ser896 NR1 IgG (1:500) was double
labelled with rat anti-IL-1RI IgG (1:600) in the spinal cord
sections; rabbit anti-iNOS IgG (1:400) and rabbit anti-nNOS IgG
(1:400) were respectively double labelled with mouse anti-GFAP
IgG (1:500), mouse anti-NeuN IgG (1:1000) or mouse anti-OX42
IgG (1:200) in the DRG sections.
Figure 1. Experimental procedures in this study (A) and mechanical allodynia in VZV infected rats (B and C). (A) The timeline
represents the period during which behavior, histochemistry, PCR and Western blot studies were performed per week after VZV infection. Intrathecal
catheterization was performed on rats and followed by 3-day recovery. The pharmacology, electrophysiology, and NOS studies were conducted at
post-infection 2 weeks when the mechanical allodynia reached the highest level. (B) Compared with Naive rats and Mock infected rats, the paw
withdrawal threshold of VZV infected rats was significantly decreased. * P,0.05, ** P,0.01 vs. Naive rats and Mock infected rats. (C) Systemic
treatment with antiviral agent valaciclovir had no effect on the development of mechanical allodynia. * P,0.05, ** P,0.01 vs. Mock infected rats. All
data were calculated as mean 6 SEM (n=10/group/week).
doi:10.1371/journal.pone.0023059.g001
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times. After staining, the sections were coverslipped with a mixture
of 50% (v/v) glycerin and 2.5% (w/v) triethylene diamine (anti-
fading agent) in PBS, and observed with a confocal laser scanning
microscope (Olympus FV1000, Tokyo, Japan) under appropriate
filters for green-emitting FITC (excitation 490 nm; emission
520 nm) and for red-emitting Cy3 (excitation 552 nm; emission
565 nm).
Western blot analysis
Rats were anesthetized and the dorsal halves of the spinal cord
innervated by the L5 dorsal roots were rapidly removed. The
collected tissue was mechanically homogenized and centrifuged.
The supernatant was collected and stored at 280uC. Protein
concentrations of the supernatant were determined using the BCA
Protein Assay Kit (Pierce, Rockford, IL, USA). Proteins of interest
were separated by SDS-PAGE electrophoresis (20 mg of total
protein per well), and transferred onto nitrocellulose membranes.
The membranes were placed in a blocking solution (TBS with
0.02% Tween and 5% non-fat dry milk powder) for 1 h, and
incubated overnight with mouse anti-GFAP IgG (1:500), mouse
anti-OX42 IgG (1:200), rabbit anti-iNOS IgG (1:400), rabbit anti-
nNOS IgG (1:400), rabbit anti-IL-1b IgG (1:300) or rabbit anti-P-
ser896 NR1 IgG (1:500). After washing, the membranes were
incubated in peroxidase-conjugated secondary antibody (1:1000;
Santa Cruz) for 1 h, and then the membranes were detected by
the enhanced chemiluminescence detection method (Amersham
Pharmacia Biotech Inc., Piscataway, NJ, USA). The densities of
protein blots were analyzed by using Labworks Software (Ultra-
Violet Products Ltd., Cambridge, UK) and normalized to b-actin
levels.
Real-time reverse transcription polymerase chain
reaction (RT-PCR)
Rats were anesthetized and L5 of the spinal dorsal horn was
rapidly harvested. Total RNA was extracted with Trizol (GIBCO/
BRL Life Technologies Inc., Grand Island, NY, USA), an RNA
isolation reagent. cDNA was synthesized with oligo (dT)12–18 using
Superscript
TM Reverse Transcriptase for RT-PCR (Invitrogen,
Carlsbad, CA, USA). The primers used were presented in Table 1.
GAPDH was served as an endogenous internal standard control.
The PCR reactions were carried out using 2 ml of cDNA, primers
specific to the gene of interest (Table 1) and the SYBRH Premix Ex
Taq
TM (Takara, Tokyo, Japan) in 20 ml reactions. Levels of PCR
product were measured using SYBR Green fluorescence collected
during real time PCR in a detection system (Applied Biosystems
7300, Foster City, CA, USA). Melting point analyses were
performed for each reaction to confirm single amplified products.
Target RNA sequence quantities were estimated from the
threshold amplification cycle number (Ct) using Sequence
Detection System software (Applied Biosystems). Expression was
normalized to GAPDH.
Electrophysiological testing
The rats were anesthetized and artificially ventilated. Core body
temperature was monitored and maintained at 37.560.5uC. A
laminectomy was performed from the T13 to L2 vertebrae to
expose the lumbosacral enlargement of the spinal cord. Extracel-
lular single unit recordings were made from L5 spinal dorsal horn
ipsilateraltoVZVinfectionwith glasscapillarymicroelectrodes(10–
15 MV filled with 0.5 M sodium acetate). The dorsal horn neurons
were identified as WDR units on the basis of their characteristic
responses: (1) having a receptive field consisting of a small low
threshold center and a large high threshold surround ipsilateral to
the recording site; (2) responding with an increasing firing rate to
brush, pressure and noxious pinch applied to the low threshold
center; (3) showing no apparent accommodation when continuous
noxious stimulation was applied. After successful identification of a
single WDR unit, the unit responsiveness to 10 s mechanical stimuli
was recorded. The spike trains were monitored with a memory
oscilloscopeandthenumbersofneuronalfiringweresimultaneously
recorded and saved on a computer via an A/D converter following
spike discriminator and counter.
Data analysis
The results were presented as mean 6 SEM. Statistical analysis
of the data was carried out with a one-way analysis of variance
(ANOVA) followed by Bonferroni post hoc analysis. Comparisons
between two means were performed by a Student’s T-test. A
Pearson correlation was used to determine the correlation between
the intensity of GFAP (Western blot) and pain behavioral
performance. Significance level was set at P,0.05. The statistics
software used was SPSS 12.0 for Windows.
Results
VZV infection induced mechanical allodynia which was
resistant to antiviral therapy
No difference in paw withdrawal threshold was observed
between naive rats (2563.5 g) and mock infected rats
(24.563.4 g), and the paw withdrawal threshold of these two
groups maintained at basal level through the period tested.
Compared to naive rats and mock infected rats, the paw
withdrawal threshold of VZV infected rats significantly decreased
at post-infection 1 week (P1) (11.561.6 g), reached the lowest
value at P2 (5.661.8 g), and thereafter maintained at low level till
P8 (n=10/group; P,0.05). After P8, the paw withdrawal
threshold of VZV infected rats gradually increased to the basal
level at P12 (Fig. 1B). On the other hand, some VZV infected rats
were treated with antiviral agent valaciclovir. However, valaciclo-
vir treatment had no effect on the development of mechanical
allodynia (decreased paw withdrawal threshold), which suggested
that continued virus infection was not required for VZV induced
allodynia (Fig. 1C).
Table 1. Primers and Taqman probe sequence for the rat
genes characterized in this experiment.
Genes Primers
GFAP Forward primer 59 TGGCCACCAGTAACATGCAA 39
Reverse primer 59 CAGTTGGCGGCGATAGTCAT 39
Taqman probe 59 CAGACGTTGCTTCCCGCAACGC 39
OX42 Forward primer 59 CTGCCTCAGGGATCCGTAAAG 39
Reverse primer 59 CCTCTGCCTCAGGAATGACATC 39
Taqman probe 59 CCCGGGACAATGCCGCGAA 39
IL-1b Forward primer 59 GCAAACAGGTCGGCGTCTT 39
Reverse primer 59 TGCGCAGCGCTAAAACTTG 39
Taqman probe 59 TGATCTCGGCCCTCTGTCCGCA 39
GAPDH Forward primer 59 CCCCCAATGTATCCGTTGTG 39
Reverse primer 59 TAGCCCAGGATGCCCTTTAGT 39
Taqman probe 59 TGCCGCCTGGAGAAACCTGCC 39
doi:10.1371/journal.pone.0023059.t001
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allodynia
Immunohistochemistry indicated that compared to naive rats
and mock infected rats, GFAP staining was significantly increased in
the spinal cord of VZV infected rats at post-infection 1 week (P1),
peaked at P2, and thereafter maintained at high level till P8.
Staining of GFAP appeared to be enhanced throughout the spinal
dorsal horn. (Fig. 2A–C). Using real-time RT-PCR, it was found
that the spinal mRNA expression of GFAP was significantly
upregulated in VZV infected rats compared to naive rats and mock
infected rats (Fig. 2D). Activated astrocytes had hypertrophied cell
bodies and thickened processes with enhanced GFAP-immunore-
activity in VZV infected rats. However, with regard to the total
number of GFAP positive cells, there was no difference between
Naı ¨ve rats and VZV infected rats (Fig. 2E). On the other hand, we
found that BrdU immunoreactivity was undetectable in both Naı ¨ve
rats and VZV infected rats in BrdU incorporation analysis, which
indicated that there was no proliferation of astrocytes in the spinal
cord of VZV infected rat (data not shown). Using Western blot, we
detected that compared to naiverats(0.2260.04) and mock infected
rats (0.260.03), GFAP expression was significantly increased in
VZV infected rats at post-infection day 3 (0.6860.15). GFAP
upregulation peaked at P2 (1.6260.3) and thereafter persisted at
high level till P8 (n=10/group; P,0.05). After P8, GFAP
expression gradually decreased to the basal level at P12 (Fig. 2F).
Furthermore, the expression level of GFAP was found to be
significantly correlated to the paw withdrawal threshold in VZV
infected group (P,0.001, r=20.868) (Fig. 2G).
NosignificantdifferenceinOX42mRNAexpressionwasobserved
among naive rats, mock infected rats and VZV infected rats (Fig. 3A).
With regard to OX42-like immunoreactivity (-LI) in spinal dorsal
horn, there was no difference between Naı ¨ve rats and VZV infected
rats (Fig. 3B). With regard to OX42 expression in spinal cord,
Western blot showed that there was no difference between naive rats,
mock infected rats and VZV infected rats at post-infection any week.
In all the mice, OX42 expression was unchanged through the period
tested (Fig. 3C). We injected LAA or minocycline intrathecally and
observed their effects on mechanical allodynia in VZV infected rats
(P2). The astrocytic specific toxin LAA significantly attenuated the
allodynia. However, the microglial specific inhibitor minocycline did
not influence mechanical allodynia (Fig. 3D).
Spinal astrocytic activation contributed to spinal central
sensitization in VZV infected rat
The responsiveness of WDR neurons was gradedly increased
with the increase in mechanical intensity (brush, pressure and
pinch) (Fig. 4A–D). The stimulus-response functional curves for
mechanical sensitivity of the spinal dorsal horn WDR neurons are
shown in each group (Fig. 4E). Compared to mock infected rats,
the responsiveness of WDR neurons was significantly enhanced
with a distinct leftward shift of the stimulus-response functional
curve in VZV infected rats, which indicated that spinal central
sensitization occurred in VZV infected rat (Fig. 4E). We injected
LAA or minocycline intrathecally and observed their effects on
increased responsiveness of WDR neurons in VZV infected rats
(P2). The astrocytic specific toxin LAA significantly attenuated the
increased responsiveness. However, the microglial specific inhib-
itor minocycline did not have any effect (Fig. 4E).
Spinal astrocytic activation depended on activation of
neuronal iNOS
Compared to naive rats and mock infected rats, iNOS expression
was significantly increased in DRG and spinal cord of VZV infected
rats (P2). However, with regard to nNOS expression in DRG and
spinal cord, there was no difference among Naive rats, Mock
infected rats and VZV infected rats (Fig. 5A and B). Also, the
number of iNOS-immunopositive but not nNOS-immunopositive
DRG neurons in VZV infected rats was significantly increased
when compared to naive rats (Fig. 5C1–C4).
At P2 in VZV infected rats, double immunofluorescent staining
of spinal cord showed that iNOS-immunoreactivity was only
localized in NeuN-immunopositive cells but not in GFAP-
immunopositive cells or OX42-immunopositive cells (Fig. 5D1).
In addition, intrathecal treatment with L-NIL (inhibitor of iNOS)
or PTIO (scavenger of NO) significantly reduced GFAP
overexpression in VZV infected rats. However, intrathecal
treatment with 7-NINA (selective inhibitor of nNOS) had no
effect on GFAP overexpression in VZV infected rats (Fig. 5D2).
Furthermore, intrathecal treatment with L-NIL or PTIO exerted
significant analgesic effect in VZV infected rats. However,
intrathecal treatment with 7-NINA had no effect on pain behavior
in VZV infected rats (Fig. 5D3). All these data indicated that VZV
infection-induced activation of neuronal iNOS may mediate the
development of spinal astrocytic activation and allodynia in VZV
infected rats.
Spinal astrocytes dramatically increased the expression
of IL-1b which was related to mechanical allodynia
At post-infection 2 week (P2) in VZV infected rats, double
immunofluorescent staining of spinal cord showed that IL-1b-
immunoreactivity was only localized in GFAP-immunopositive
cells but not in OX42-immunopositive cells (Fig. 6A–C9). Western
blot analysis showed that compared to naive rats (0.0460.006) and
mock infected rats (0.04360.005), IL-1b expression was signifi-
cantly increased in VZV infected rats at post-infection 1 week (P1)
(0.560.11). IL-1b upregulation peaked at P2 (1.160.16), and
thereafter persisted at high level till P8 (n=10/group; P,0.05).
After P8, IL-1b expression gradually decreased to the basal level at
P12 (Fig. 6D). Thus, the time course of IL-1b expression was
similar to that of GFAP expression. At P2 in VZV infected rats,
intrathecally administered LAA could significantly down-regulate
IL-1b overexpression (0.2860.07) (Fig. 6D). Using real-time RT-
PCR, it was found that the spinal mRNA expression of IL-1b was
significantly upregulated in VZV infected rats compared to naive
rats and mock infected rats (Fig. 6E). At P2 in VZV infected rats,
we injected pentoxifylline (cytokine inhibitor) or IL-1ra (interleu-
kin-1 receptor antagonist) intrathecally and observed their effects
on mechanical allodynia in VZV infected rats. Both pentoxifylline
and IL-1ra could significantly attenuated the allodynia (Fig. 6F). In
addition, we found that intrathecal treatment with pentoxifylline
or IL-1ra had no effect on GFAP overexpression in VZV infected
rats (data not shown), which indicated that IL-1b may had no
effect on spinal astrocytes in VZV-infected rats.
IL-1b induced NMDA receptor phosphorylation which
contributed to mechanical allodynia
At P2 in VZV infected rats, double immunofluorescent staining
of spinal cord showed that P-NR1-immunoreactivity and IL-1RI-
immunoreactivity were only localized in NeuN-immunopositive
cells, and P-NR1-immunoreactivity and IL-1RI-immunoreactivity
were totally double-labeled (Fig. 7A–C).
Western blot analysis showed that compared to naive rats
(0.0560.009) and mock infected rats (0.0460.006), the phosphor-
ylation of NR1 was significantly increased in VZV infected rats at
P1 (0.3860.06). The phosphorylation of NR1 peaked at P2
(0.6860.12), and thereafter persisted at high level till P8 (n=10/
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decreased to the basal level at P12 (Fig. 7D). Thus, the time course
of the level of P-NR1 was similar to that of IL-1b expression or
GFAP expression. At P2 in VZV infected rats, intrathecally
administered LAA, pentoxifylline or IL-1ra could significantly
reverse infection induced phosphorylation of NR1 (Fig. 7D). At P2
in VZV infected rats, we injected AP5 (NMDA receptor
antagonist) or MK-801 (non-competitive NMDA receptor antag-
onist) intrathecally and observed their effects on mechanical
allodynia in VZV infected rats. Both AP5 and MK-801 could
significantly attenuated the allodynia (Fig. 7E). Most importantly,
we found that neither MK-801 nor AP5 could affect the motor
performance of VZV infected rats in the rotarod test, which
indicated that the antinociceptive effects of MK-801 or AP5 did
not rely on impairments of motor function (data not shown). In
addition, it was found that intrathecal treatment with MK-801 or
AP5 had no effect on GFAP or IL-1b overexpression in VZV
infected rats (data not shown).
Figure 2. Spinal astrocytes were activated in VZV infected rats, which was significantly correlated to mechanical allodynia. (A–C)
Compared with Naive rats and Mock infected rats, GFAP-like immunoreactivity (-LI) in spinal dorsal horn of VZV infected rats was significantly
increased. Bar=200 mm. (D) Real-time RT-PCR showed that spinal mRNA expression of GFAP was significantly upregulated in VZV infected rats
compared to naive rats and mock infected rats. (E) With regard to the total number of GFAP positive cells, there was no difference between Naı ¨ve rats
and VZV infected rats. Bar=10 mm. (F) Compared to Naive rats and Mock infected rats, Western blot analysis showed that spinal GFAP expression was
significantly increased in VZV infected rats. (G) The expression level of GFAP was found to be significantly correlated to the paw withdrawal threshold
in VZV infected rats (P,0.001, r=20.868). All data were calculated as mean 6 SEM (n=10/group/week). * P,0.05, ** P,0.01 vs. Naive rats and Mock
infected rats; DP,0.05 vs. post-infection 2 weeks rats.
doi:10.1371/journal.pone.0023059.g002
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The present study was the first time to provide evidence that
spinal astrocytic activation contributed to mechanical allodynia in
VZV-infected rats. The neural mechanism in astrocyte incudced
allodynia may be that spinal activated astrocytes dramatically
increased the expression of IL-1b which may induce NMDA
receptor phosphorylation in spinal dorsal horn neurons to enhance
neuronal activity and pain transmission.
Spinal astrocyte but not microglia was activated in VZV
infected rat, which contributed to experimental
postherpetic neuralgia
PHN is characterized by the development of hyperalgesia (a
facilitated behavioral response to painful stimuli), mechanical
allodynia (the perception of innocuous stimuli as painful) and
spontaneous pain, which are also features of other forms of
neuropathic pain [32]. Although it is still unclear how latent
VZV infection interacts with the nervous system to induce pain
behavioural changes, the underlying pathophysiological mech-
anisms of PHN may be similar to other forms of neuropathic
pain. Spinal cord glia (astrocyte and microglia) are now posited
to be dynamically and powerfully involved in diverse exagger-
ated pain states [12,13]. While cumulating evidence suggested
the involvement of microglia in varius models of persistent pain
[33], such as spinal nerve ligation induced pian [34], formalin
induced inflammatory pain [35], spinal cord injury induced
pian [36] and so on, emerging studies have suggested the critical
role of spinal astrocytes in some pathological pain states,
including neuropathic pain [25], inflammatory pain [37],
visceral pain [38] and diabetic pain [39]. To identify the
potential involvement of which subtype of glial cell (astrocyte or
microglia) in PHN, we studied the expression of different glia
activation markers in the spinal cord and the influence of
different glial inhibitors on mechanical allodynia in VZV-
infected rats. We found that GFAP (astrocytic activation
marker) but not OX42 (microglial activation marker) was
significantly increased in the spinal cord of VZV infected rat.
Figure 3. Spinal microglia was not activated in VZV infected rats, astrocytic specific inhibitor LAA but not microglial specific
inhibitor minocycline could attenuate mechanical allodynia. (A) No significant difference in OX42 mRNA expression in spinal cord was
observed among naive rats, mock infected rats and VZV infected rats. (B) With regard to OX42-like immunoreactivity (-LI) in spinal dorsal horn, there
was no difference between Naı ¨ve rats and VZV infected rats. Bar=200 mm. (C) With regard to OX42 expression in spinal cord, there was no difference
among Naive rats, Mock infected rats and VZV infected rats. In VZV infected rats, OX42 expression was unchanged through the period tested. (D)
Intrathecal injection of LAA significantly attenuated the allodynia. However, minocycline did not influence the allodynia. All data were calculated as
mean 6 SEM (n=10/group). * P,0.05, ** P,0.01 vs. VZV+Saline group or VZV+minocycline group in D.
doi:10.1371/journal.pone.0023059.g003
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that of mechanical allodynia. Astrocytic specific inhibitor LAA
but not microglial specific inhibitor minocycline significantly
attenuated the allodynia, which elucidated that astrocytic
activation but not microglial activation contributed to allodynia
in VZV infected rat. To the best of our knowledge, we are the
f i r s tt or e p o r tt h a tt h i sg l i ac e l l( a s t r o c y t e )p l a y sa ni m p o r t a n t
role in mechanical allodynia of VZV infected rat.
Similar to our finding, a recent study showed that spinal
astrocytes but not microglia may be a crucial component of type 2
diabetes-induced neuropathic pain [39]. However, another recent
study indicated that spinal microglia are more activated than
astrocytes in the neuropathic pain of chronic constriction injury to
the sciatic nerve [40]. Interestingly, a previous study showed that
both spinal astrocytes and microglia were activated in the
neuropathic pain of partial peripheral nerve injury [41]. All the
above results indicated that spinal astrocytic activation and/or
microglial activation play crucial roles in different pathological
pain states. The discrepancy in the activation of glial cell subtypes
(astrocyte or microglia) may be attributed to different pathogenetic
mechanism within different models of neuropathic pain. Never-
theless, our promising findings regarding LAA-induced alleviation
of mechanical allodynia in VZV infected rat suggest that
pharmacological antagonism of astrocytic activation in spinal
cord may offer a great advantage in the treatment of PHN.
VZV infection-induced activation of neuronal iNOS may
contribute to spinal astrocytic activation
A key factor in the neural plasticity underlying neuropathic pain
is altered expression of neurotransmitters in sensory dorsal root
ganglion (DRG) neurons [42]. Previous studies have shown that
there was an increased expression of calcium channel, sodium
channels, the neuropeptide and activating transcription factor-3 in
DRG of VZV-infected rats [7]. In the present study, it was found
that iNOS but not nNOS expression was significantly increased in
DRG and spinal dorsal horn of VZV infected rats when compared
with control rats. Also, the number of iNOS-immunopositive
DRG neurons in VZV infected rats was significantly increased.
iNOS could produce an excessive amount of NO, a molecule
which is one of the important substances implicated in diverse
exaggerated pain states [43]. NO has been shown to regulate
expression of GFAP in primary cultured astrocytes [44,45,46].
Here, we hypothesized that VZV infection-induced activation of
iNOS may be a key mechanism for the development of spinal
astrocytic activation in VZV infected rat. Intrathecal treatment
with L-NIL (inhibitor of iNOS) or PTIO (scavenger of NO)
significantly reduced GFAP overexpression whereas 7-NINA
(selective inhibitor of nNOS) had no effect, which suggested that
NO originating from iNOS may function as an initiator of
astrocyte activation in VZV-infected rats. All these results indicate
that neuronal input and related chemical mediators may be
essential for triggering spinal astrocytic activation after VZV
infection.
Spinal astrocytic activation induced central sensitization
of spinal neurons in VZV infected rat
Spinal dorsal horn wide dynamic range (WDR) neurons are
more plastic following tissue injury and are believed to be
responsible for the spinally-organized nociceptive transmission
[42]. In this study, electrophysiological recording from WDR
neurons in the lumbar (L4–L5) spinal dorsal horn in VZV infected
rat showed significantly increased responsiveness to stimuli, which
indicated that spinal central sensitization occurred in VZV
infected rat, and this central sensitization contributed to the
allodynia seen in VZV infected rats. Most importantly, the
astrocytic specific toxin LAA significantly attenuated the increased
responsiveness of WDR neurons, which demonstrated that spinal
astrocytes play an important role in the mediation of excessively
increased activity of dorsal horn neurons. These results dictate a
necessity for subsequent detailed studies of signal coupling between
astrocytes and neurons in spinal dorsal horn of VZV infected rat.
The neural mechanism of astrocyte induced allodynia
may be ‘‘Astrocyte-Cytokine-NMDAR-neuron’’ pathway
Under pathological condition, activated astrocytes could release
proinflammatory cytokines, of which IL-1b has become the
research focus [12,15]. In the present study, IL-1b expression
was significantly increased in VZV infected rat compared to
control rat, and IL-1b was selectively localized in astrocytes. In
support of our findings, previous studies also reported selective
localization of increased IL-1b in spinal astrocytes in bone cancer
pain model [47] and Complete Freunds adjuvant-induced
inflammatory pain model [37]. Furthermore, intrathecally injected
pentoxifylline (cytokine inhibitor) or IL-1ra (interleukin-1 receptor
antagonist) could significantly attenuated the allodynia in this
study. Similar to our data, previous studies also showed that
intrathecally application of IL-1ra could exert significant analgesic
effect in Complete Freunds adjuvant-induced inflammatory pain
model [48] and L5 spinal nerve transection-induced neuropathic
Figure 4. Astrocytic activation contributed to spinal central
sensitization in VZV infected rats. Comparative recordings of
responsiveness of spinal dorsal horn wide dynamic range (WDR)
neurons to mechanical (brush, pressure and pinch) stimuli in Mock
infected group (A), VZV infected group (B), VZV+LAA group (C) and
VZV+minocycline group (D). (A–D) The responsiveness of WDR neurons
was gradedly increased with the increase in mechanical intensity (brush,
p r e s s u r ea n dp i n c h ) .( E )C o m p a r e dt oM o c ki n f e c t e dr a t s ,t h e
responsiveness of WDR neurons was significantly enhanced with a
distinct leftward shift of the stimulus-response functional curve in VZV
infected rats. The astrocytic specific toxin LAA significantly attenuated
the increased responsiveness. However, the microglial specific inhibitor
minocycline did not have any effect. * P,0.05 vs. Mock infected rats;
DP,0.05 vs. VZV infected rats.
doi:10.1371/journal.pone.0023059.g004
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astrocytic specific inhibitor LAA could significantly down-regulate
IL-1b expression in the present study. Consistent with our data, a
recent study also reported that IL-1b overexpression could be
blocked by intrathecally administered LAA in a type 2 diabetes-
induced neuropathic pain [39]. Taken together, all these results
strongly suggest that activated astrocytes are the only source of IL-
1b release which contributed to mechanical allodynia in VZV
infected rat.
Recent studies indicate that spinal NMDA receptor activation
mainly involves phosphorylation of the NR1 (a subunit of NMDA
receptor), which is strongly correlated with induction and
maintenance of persistent pain [8,9]. Here, it was shown that
spinal phosphorylation of the NR1 was significantly enhanced in
VZV infected rat compared to control rat, and P-NR1-
immunoreactivity were only localized in spinal neurons. In
support of our findings, previous studies also reported significantly
enhanced phosphorylation of the NR1 subunit in spinal neurons in
peripheral heat stimulation-induced pain model [10], trigeminal
inflammation pain model [50] and partial sciatic nerve ligation-
induced neuropathic pain model [11]. Furthermore, intrathecally
injected AP5 (NMDA receptor antagonist) or MK-801 (non-
competitive NMDA receptor antagonist) could significantly
attenuated the allodynia in VZV infected rat in this study, which
indicated that NR1 phosphorylation induced activation of NMDA
receptor surely contributed to PHN. Similar to our data, previous
Figure 5. VZV infection induced spinal astrocytic activation depended on activation of iNOS. (A and B) Compared to Naive rats and Mock
infected rats, iNOS expression was significantly increased in dorsal root ganglion (DRG) and spinal cord of VZV infected rats. With regard to nNOS
expression in DRG and spinal cord, there was no difference among Naive rats, Mock infected rats and VZV infected rats. (C1–C4) The number of iNOS-
immunopositive but not nNOS-immunopositive DRG neurons in VZV infected rats was significantly increased compared to Naive rats. Bars=100 mm
(C1) and 20 mm (C2). (D1) iNOS-immunoreactivity was localized in NeuN-immunopositive cells but not in GFAP-immunopositive cells or OX42-
immunopositive cells in spinal cord of VZV infected rats. Bar=50 mm. (D2) Intrathecal treatment with L-NIL (selective inhibitor of iNOS) or PTIO
(scavenger of NO) significantly reduced GFAP overexpression in spinal cord of VZV infected rats. However, intrathecal treatment with 7- NINA
(selective inhibitor of nNOS) had no effect on GFAP overexpression in VZV infected rats. (D3) Intrathecal treatment with L-NIL or PTIO exerted
significant analgesic effect in VZV infected rats. However, intrathecal treatment with 7-NINA had no effect on pain behavior in VZV infected rats. All
data were calculated as mean 6 SEM (n=10/group). ** P,0.01 vs. Naive rats and Mock infected rats in A–C. * P,0.05 vs. saline (vehicle) treated VZV
infected rats in D2.
doi:10.1371/journal.pone.0023059.g005
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PLoS ONE | www.plosone.org 9 September 2011 | Volume 6 | Issue 9 | e23059Figure 6. IL-1b overexpression in spinal cord was related to mechanical allodynia in VZV infected rats, and activated astrocytes
were the only source of IL-1b. (A–C9) Double immunofluorescent staining showed that IL-1b-immunoreactivity was localized in GFAP-
immunopositive cells but not OX42-immunopositive cells in spinal cord of VZV infected rats. Bars=20 mm. (D) IL-1b expression was significantly
increased in spinal cord of VZV infected rats compared to Naive rats and Mock infected rats. Intrathecal treatment with LAA (astrocytic specific toxin)
significantly reduced IL-1b overexpression in VZV infected rats. (E) Using real-time RT-PCR, it was found that the spinal mRNA expression of IL-1b was
significantly upregulated in VZV infected rats compared to naive rats and mock infected rats. (F) Intrathecal injection of Pentoxifylline (cytokine
inhibitor) or IL-1ra (interleukin-1 receptor antagonist) could significantly attenuated the allodynia. All data were calculated as mean 6 SEM (n=10/
group). * P,0.05, ** P,0.01 vs. Naive rats and Mock infected rats; DP,0.05 vs. post-infection 2 weeks rats in D and E. * P,0.05, ** P,0.01 vs. saline
(vehicle) treated VZV infected rats in F.
doi:10.1371/journal.pone.0023059.g006
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PLoS ONE | www.plosone.org 10 September 2011 | Volume 6 | Issue 9 | e23059Figure 7. IL-1b released from astrocyte induced NMDA receptor phosphorylation in spinal dorsal horn neurons in VZV infected rats,
which was related to mechanical allodynia. (A–C) Double immunofluorescent staining showed that P-NR1-immunoreactivity and IL-1RI-
immunoreactivity were totally double-labeled in spinal dorsal horn of VZV infected rats. Bar=50 mm. (D) The phosphorylation of NR1 was significantly
increased in VZV infected rats compared to Naive rats and Mock infected rats. Intrathecal treatment with LAA (astrocytic specific toxin), PF (cytokine
inhibitor) or IL-1ra (interleukin-1 receptor antagonist) could significantly reduce the phosphorylation of NR1 in VZV infected rats. (E) Intrathecal
injection of AP5 (NMDA receptor antagonist) or MK-801 (non-competitive NMDA receptor antagonist) could significantly attenuated the allodynia. All
data were calculated as mean 6 SEM (n=10/group). * P,0.05, ** P,0.01 vs. Naive rats and Mock infected rats; DP,0.05 vs. post-infection 2 weeks
rats in D. * P,0.05, ** P,0.01 vs. saline (vehicle) treated VZV infected rats in E.
doi:10.1371/journal.pone.0023059.g007
Spinal Astrocytes and Postherpetic Neuralgia
PLoS ONE | www.plosone.org 11 September 2011 | Volume 6 | Issue 9 | e23059studies also showed that intrathecally application of NMDA
receptor antagonists could exert antiallodynic effect in chronic
constriction injury-induced neuropathic pain model [8] and
peripheral heat stimulation-induced pain model [10].
IL-1R, a subfamily of the Toll/IL-1 receptor superfamily, is the
endogenous binding receptor for IL-1b. IL-1R contains two
subtypes: the type I IL-1R (IL-1RI) and the type II IL-1R. IL-1RI
is a transmembrane molecule and responsible for IL-1 signaling
and the type II IL-1R lacks an intracellular domain and is
incapable of signal transduction [51]. The present study showed
that IL-1RI-immunoreactivity were only localized in spinal
neurons. Similar to our finding, a previous study also reported
selective localization of IL-1RI in spinal dorsal horn neurons in a
inflammatory pain model [52]. In the present study, the time
course of the phosphorylation of the NR1 was similar to that of IL-
1b or GFAP expression, and neuronal P-NR1-immunoreactivity
and neuronal IL-1RI-immunoreactivity were totally double-
labeled, which strongly supported a close interaction of IL-1b
signaling with neuronal NMDA receptor. Thus, it was hypothe-
sized that IL-1b mediated allodynia in VZV infected rat may be
through binding its receptor IL-1RI on the neurons, and then
possibly via intracellular signal transduction leading to the
phosphorylation of NMDA receptor NR1 subunit. As expected,
subsequent data showed that intrathecally administered LAA,
pentoxifylline or IL-1ra each could blocked the phosphorylation of
the NR1 in this study. Similar to our finding, two previous studies
reported that IL-1ra could block the phosphorylation of the NR1
in inflammatiory pain models [30,50]. Also, a recent study showed
that phosphorylation of the NR1 could be alleviated by intrathecal
application of LAA in spinal nerve ligation-induced neuropathic
pain model [53]. Therefore, all the above results indicated that
spinal activated astrocytes dramatically increased the expression of
IL-1b which directly bind to its receptor IL-1RI to induce NMDA
receptor phosphorylation in spinal dorsal horn neurons, and
finally pain transmission was enhanced.
In summary, the present study suggestted that spinal activated
astrocytes may be one of the most important etiological factors of
PHN and ‘‘NO-Astrocyte-Cytokine-NMDAR-Neuron’’ pathway
may be the detailed molecular mechanisms underlying astrocyte
induced allodynia in PHN. These findings suggest that spinal
astrocytic inhibition may hold a therapeutic promise in the
treatment of postherpetic neuralgia.
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